Search Results
Feb 18, 2026, 09:22 ET CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
technologies for heavy-duty automated guided vehicles, breaking foreign technological constraints. DJI, backed by sharp market insight and sustained R&D investment, has become a global leader in drones.Beyond boosting consumption and innovation, the private sector can play a greater role in China's
More news about: CGTN
Feb 18, 2026, 09:05 ET 2026 Palisade Hybrid Wins Edmunds' Highest Honor: Edmunds Top Rated Best of the Best
headquarters in California, the Hyundai Motor Manufacturing Alabama assembly plant, the all-new Hyundai Motor Group Metaplant America, several cutting-edge R&D facilities and more than 855 independent dealers. These operations are part of Hyundai Motor Group, which is
More news about: Hyundai Motor America
Feb 18, 2026, 09:03 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
doi:10.21037/tp.2019.07.10 Data on file; estimated number of premature infants fed Prolacta's products from January 2007 to May 2025. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242.
More news about: Prolacta Bioscience
Feb 18, 2026, 09:00 ET ADDF Awards Prestigious 2026 Melvin R. Goodes Prize to Alzheimer's Research Pioneer Randall J. Bateman, MD
Melvin R. Goodes Prize for Excellence in Drug Development was established in 2015 in honor of Melvin R. Goodes, former CEO of Warner-Lambert Company, to honor scientists whose work has made exceptional and
More news about: Alzheimer's Drug Discovery Foundation
Feb 18, 2026, 09:00 ET DailyPay Announces Appointment of Jennifer R. Jackson to its Board of Directors
DailyPay, the leading On-Demand Pay platform and financial wellness solution, today announced the appointment of Jennifer R. Jackson to its Board of Directors, effective February 13, 2026.
More news about: DailyPay
Feb 18, 2026, 09:00 ET AVEO Oncology, an LG Chem company, Announces Completion of the First Interim Analysis in the Global Phase 3 FIERCE-HN Study
and safety of ficlatuzumab plus cetuximab to a control arm of placebo plus cetuximab in participants with HPV-negative R/M HNSCC. The trial is open to adults with a primary diagnosis of R/M HNSCC. Eligible participants must have failed prior therapy with chemotherapy and an anti-programmed cell death protein
More news about: AVEO, an LG Chem company
Feb 18, 2026, 09:00 ET EV Group Unveils Next-Generation EVG®120 Resist Processing System for High-Volume Manufacturing
leverages EV Group's decades of experience in photoresist and lithography processing to support the rapidly diversifying needs of our customers from R&D through volume production," stated Dr. Thomas Glinsner, corporate technology director at EV Group. "With new capabilities such as in-situ metrology
More news about: EV Group
Feb 18, 2026, 09:00 ET Following Successful Launch, Lollipop Racing's "Episode Zero" Now Streaming - A First Look at the Racing Franchise of the Future
Porsche appears through two of its most advanced performance platforms, the 992-generation 911 GT3 RS and the new 992.2 911 GT3 R Evo, positioned as the hero competition vehicle within the franchise. As the Official OEM Partner, Porsche grounds Lollipop Racing in true motorsport
More news about: The Feature, Inc.
Feb 18, 2026, 09:00 ET Blue Earth Diagnostics to Highlight New POSLUMA® (Flotufolastat F 18) Study Results in Prostate Cancer at the 2026 ASCO Genitourinary Symposium (ASCO GU)
poster presentation sessions will take place on Thursday, February 26, 2026 at 11:30 – 12:45 p.m. and 5:45 – 6:45 p.m. (PST) at the Hall of the George R. Moscone Convention Center, and will also be available On Demand.Blue Earth Diagnostics invites participants at ASCO GU to attend the presentations
More news about: Blue Earth Diagnostics
Feb 18, 2026, 08:56 ET GunsAmerica Names Best of SHOT Show 2026 Editor's Choice Award Winners
Optic: Garmin Zero L60i Laser RangefinderBest Suppressor: Ambient Arms SuppressorsEditor's Choice: Nocpix Quest H50R Thermal BinocularBest Firearm Overall: Seekins Precision SICRead the full announcements about these products and other new product
More news about: GunsAmerica
Feb 18, 2026, 08:53 ET Four New Astronauts Arrive at Space Station for Long-Duration Science Expedition
months, the ISS National Lab will highlight additional projects launching on cargo resupply missions through NASA. To learn more about results from R&D conducted on the ISS, subscribe to
More news about: International Space Station National Lab
Feb 18, 2026, 08:51 ET HiveAuto, Inc. Appoints Victor Young to Board of Directors, Strengthening Dealer Alignment and Automotive Strategy
and strategic involvement are invaluable.""Victor brings a level of strategic rigor that's critical at this stage of our growth," said Charles R. Campbell, CEO of HiveAuto, Inc. "His experience as both an operator and investor strengthens our board and reinforces the long-term accountability we're
More news about: HiveAuto, Inc.
Feb 18, 2026, 08:40 ET Mecademic lève 21 millions de dollars pour accélérer sa croissance mondiale
finance stratégique. Les fondateurs demeurent au cœur de l'exécution : Jonathan Coulombe (CTO) dirige l'innovation technologique, Éric Boutet (VP R&D) supervise le développement de produits, Philippe Jacome (COO) assure les opérations mondiales et Ilian Bonev agit comme conseiller expert en robotique.À
More news about: Mecademic Industrial Robotics
Feb 18, 2026, 08:37 ET North Texas Smiles Introduces BRĒTH Method™: A Non-Surgical, Airway-First Approach to Improving Children's Sleep, Focus, and Development
Developed by Dr. Justin R. Warcup, DDS, the proprietary BRĒTH Method™ applies evidence-based airway principles to pediatric sleep, growth, and developmental healthFORT WORTH, Texas, Feb. 18, 2026
More news about: North Texas Smiles
Feb 18, 2026, 08:35 ET Mecademic Secures Strategic Funding to Drive Global Expansion
continues to lead core operations:Jonathan Coulombe (CTO): Technological innovation.Éric Boutet (VP R&D): Product development.Philippe Jacome (COO): Global operations.Ilian Bonev: Senior robotics advisor.About
More news about: Mecademic Industrial Robotics
Feb 18, 2026, 08:01 ET Datacor Announces Winter 2026 Product Release with New AI-Driven Capabilities
considerationsEngineering: Faster, more accurate process simulation and modeling enhancements to support design, analysis, and collaboration from R&D through operations"This release represents an important step forward in how we support our customers and the industries they serve," said
More news about: Datacor, Inc.
Feb 18, 2026, 07:35 ET Knight Therapeutics anuncia a submissão regulatória de NIKTIMVO® (axatilimabe) no Brasil
o NIKTIMVO® (axatilimabe)Niktimvo® (axatilimabe) é um anticorpo bloqueador do receptor do fator estimulador de colônias 1 (CSF-1R) pioneiro na sua classe, aprovado para uso nos EUA para o tratamento da doença do enxerto contra o hospedeiro (DECH) crônica após falha de pelo menos
More news about: Knight Therapeutics Inc.
Feb 18, 2026, 07:35 ET Knight Therapeutics anuncia la solicitud de autorización regulatoria de NIKTIMVO® (axatilimab) en Brasil
NIKTIMVO® (axatilimab)NIKTIMVO® (axatilimab) es un anticuerpo bloqueador del receptor del factor estimulante de colonias 1 (CSF-1R), primero en su clase, aprobado para su uso en los EE. UU. para el tratamiento de la enfermedad de injerto contra huésped (EICH) crónica después del
More news about: Knight Therapeutics Inc.
Feb 18, 2026, 07:30 ET RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer
recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). The study includes five cohorts, including Cohort 1, which studied RYBREVANT FASPRO™ as monotherapy in patients with human papillomavirus (HPV)-unrelated R/M HNSCC who had received prior platinum-based chemotherapy and
More news about: Johnson & Johnson
Feb 18, 2026, 07:17 ET Implantica presents the Year-end Report (Q4 2025) on February 25 at 15:00 CET
https://news.cision.com/implantica/r/implantica-presents-the-year-end-report--q4-2025--on-february-25-at-15-00-cet,c4309449The following files are available for download:
More news about: Implantica
Feb 18, 2026, 07:12 ET Intracom Telecom Unveils 15Gbps UltraLink-GX80 Advanced E-Band Solution
IT solutions. Intracom Telecom serves telecom operators, public authorities and large public and private enterprises. The Group maintains its own R&D and production facilities and has operating facilities worldwide. For more information, visit
More news about: Intracom Telecom
Feb 18, 2026, 07:07 ET ActiveState Unifies 79M Components to Launch World's Largest Secure Open Source Catalog
efforts. ActiveState's catalog now covers the most popular languages used in enterprise software development, including Java, Javascript, Go, Python, and R, among others, and offers the widest breadth and depth of any open source catalog in the market today. This release moves beyond scanners and image‑only
More news about: ActiveState
Feb 18, 2026, 07:04 ET Univar Solutions rozszerza ofertę składników dzięki umowie na wyłączność na dystrybucję kwasu glikolowego w regionie EMEA
oraz czyszczenia przemysłowego.ROTTERDAM (Holandia), 18 lutego 2026 r. /PRNewswire/ - Univar Solutions B.V., spółka zależna Univar Solutions LLC („Univar Solutions" lub „Spółka"), czołowego globalnego dostawcy rozwiązań
More news about: Univar Solutions LLC
Feb 18, 2026, 07:01 ET Analog Devices Reports Fiscal First Quarter 2026 Financial Results
continues to be the result of relentless innovation to solve our customers toughest problems and deliver enduring business impact. Our investments in R&D and the customer experience from design to delivery continue to position us to create outstanding value for shareholders and customers alike." "During
More news about: Analog Devices, Inc.